Mode
Text Size
Log in / Sign up
N/A N=17 Randomized Single-blind Prevention

Adapted Lifestyle-integrated Functional Exercise Program for Medically Underserved Older Adults

Accidental Fall

Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcome: Primary: The Berg Balance Scale (BBS) — 40.63; 35.25; 38.38; 35.88 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Adapted LiFE (Behavioral); Attention control (Behavioral)
Age
Older Adult · 70+ yrs
Sex
All
Sponsor
Washington University School of Medicine
Primary completion
Jan 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
The Berg Balance Scale (BBS)
40.63; 35.25; 38.38; 35.88
SECONDARY
The Self-Reported Habit Index (SRHI)
47.50; 57.13
SECONDARY
The Activities-specific Balance Confidence Scale (ABC)
60.77; 52.46; 60.63; 60.7
SECONDARY
The Short Physical Performance Battery (SPPB)
6.38; 5.25; 5.25; 5.38
SECONDARY
Center of Pressure (CoP) Path (cm)
0.59; 0.67; 0.68; 0.61; 0.59; 0.69
SECONDARY
Center of Pressure (CoP) Velocity (cm/s)
2.38; 1.96; 2.59; 1.96; 3.22; 2.89
SECONDARY
Lower Extremity Muscle Strength
18.11; 19.86; 18.73; 21.58; 17.10; 15.97

Summary

This study will test the feasibility of a study design for the Adapted Lifestyle-integrated Functional Exercise (LiFE) program for medically underserved older adults and to explore factors related to implementation. A feasibility trial will be conducted with a total of 16 participants. The control group will receive flexibility exercise program as attention control.

Eligibility Criteria

Inclusion Criteria

  • (1) age 70 or older;
  • (2) live independently;
  • (3) live in a medically underserved/health professional shortage area;
  • (4) self-report two falls or one injurious fall.

Exclusion Criteria

  • (1) Short Blessed Test score ≥8, indicating cognitive impairment consistent with dementia;
  • (2) inability to stand independently with a walking device;
  • (3) having a serious health condition with a physician's order where exercise is contraindicated.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03704194). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search